drug · antibody
ficlatuzumab
Phase 3updated 3mo agoby AVEO Pharmaceuticals Inc🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 10 investigational indications.
targets
Hepatocyte growth factor
all catalysts(0)
nothing on the calendar yet
Trials studying ficlatuzumab
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 46m ago
Found something off?
comments(0)
5-min edit window · permanent after that